期刊文献+

不完全川崎病40例临床分析 被引量:1

原文传递
导出
摘要 目的总结不完全川崎病(KD)的临床特点,以利于早期诊断和治疗。方法对1995年6月-2007年10月本院收治的40例不完全川崎病进行回顾性分析。结果不完全川崎病在婴儿期发生率较高,冠状动脉病变发生率与典型川崎病相似,临床表现中最常见的是发热,皮疹,恢复期脱皮,口咽黏膜弥漫性充血、皲裂,结膜充血;其次是草莓舌、手足硬性水肿,颈淋巴结肿大最少见。结论提高对不完全川崎病的早期诊断及治疗,可减少小儿后天获得性心脏病的发病率。
出处 《中国医师杂志》 CAS 2009年第2期221-223,共3页 Journal of Chinese Physician
  • 相关文献

参考文献10

二级参考文献91

  • 1王琍,林毅,苏英姿,汪芸,赵地,吴铁吉.283例川崎病的临床分析[J].中华儿科杂志,2004,42(8):609-612. 被引量:84
  • 2于宪一.川崎病治疗的现状和展望[J].实用儿科临床杂志,2004,19(11):922-924. 被引量:42
  • 3王鸿利.广泛开展血小板检测及其临床应用[J].中华医学检验杂志,1996,19(3):137-138. 被引量:112
  • 4吴瑞平.诸福棠实用儿科学(第6版)[M].北京:人民卫生出版社,1996.444.
  • 5吴瑞萍 胡亚美 江载芳.诸福棠实用儿科学[M](第6版)[M].北京:人民卫生出版社,1996.2416-2419.
  • 6Gvuzman-Cottrill JA, Shulman ST. Recent developments and controversies in Kawasaki disease [ J ]. Minerva Pediatr, 2004,56 ( 1 ):51-61.
  • 7O'Malley T,Langhorne P,Etton RA,et al.Platelet size in stroke patients[J ].Stroke,1995,26(6):995-999.
  • 8Tsuda E, Kamiya T, Kimura K, et al. Coronary artery dilatation exceeding 4.0 mm during acute kawasaki disease predicts a high probability of subsequent late intima-medial thicking[J ]. Pediatr Cardiol,2002,23(1) :9-14.
  • 9Hashino K, Ishii M, Iemura M, et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int, 2001,43:211-217.
  • 10Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr,1996,128:146-149.

共引文献441

同被引文献13

  • 1Manlhiot C, Christie E, McCrindle BW, et al. Complete and in- complete Kawasaki disease: two sides of the same coin. Eur J Ped- iatr, 2012,171 (4) :657-662.
  • 2Sudo D, Monobe Y, Yashiro M, et al. Coronary artery lesions of incomplete Kawasaki disease : a nationwide survey in Japan. Eur J Pediatr,2012,171 (4) :651-656.
  • 3Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int, 2005,47 (2) :232-234.
  • 4Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int, 2005,47(6) :711-732.
  • 5Sahebari M, Hater MR, Rezaieyazdi Z, et al. CorrelatiQn between serum levels of soluble Fas ( CD95/Apo-1 ) with disease activity insystemic lupus erythematosus patients in Khorasan, Iran. Arch I- ran Med, 2010,13(2) :135-142.
  • 6Dubikov AI, Kaliniehenko SG. Small molecules regulating apopto- sis in the synovium in rheumatoid arthritis. Scand J Rheumatol, 2010,39(5) :368-372,.
  • 7Cardinal H, Brophy JM, Bogaty P, et al. Usefuhaess of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol, 2010,105 (6) :797-803.
  • 8Esen O, Agus HZ, Guler GB, et al. Relationship between circu- lating soluble Fas ligand and preexisting left ventricular hypertro- phy in the setting of left ventricular remodeling after acute myo- cardial infarction. Coron Artery Dis, 2011,22(5) :294-298.
  • 9Charoensri N, Porrtratanarangsi S. D-dimer plasma levels in NSTE-ACS patient. J Med Assoc Thai, 2011,94 Suppl 1:539- S45.
  • 10Wang Y, Liu ZH, Zhang HL, et al. Predictive value of D-dimer test for recurrent venous thromboembolism at hospital discharge in patients with acute pulmonary embolism. J Thromb Thrombolysis, 2011,32(4) :410-416.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部